Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo.

Julie Beitz, Paolo Calabresi(Università Cattolica del Sacro Cuore), A. Raymond Frackelton(Brown University), Jun Kato, Douglas A. Lappi(Advanced Targeting Systems (United States)), Jeffrey W. Clark(Massachusetts General Hospital), Andrew Baird(University of Liverpool), P. Davol, Miguel Ángel Medina(University of Bonn)
PubMed
January 1, 1992
Cited by 65

Related Papers

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2014|2k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers
|Journal of Clinical Oncology|2012|1.6k
Estrogen-Induced Activation of Erk-1 and Erk-2 Requires the G Protein-Coupled Receptor Homolog, GPR30, and Occurs via Trans-Activation of the Epidermal Growth Factor Receptor through Release of HB-EGF
|Molecular Endocrinology|2000|1.3k